You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 212045


✉ Email this page to a colleague

« Back to Dashboard


NDA 212045 describes KLOXXADO, which is a drug marketed by Hikma and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the KLOXXADO profile page.

The generic ingredient in KLOXXADO is naloxone hydrochloride. There are twelve drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.
Summary for 212045
Tradename:KLOXXADO
Applicant:Hikma
Ingredient:naloxone hydrochloride
Patents:5
Pharmacology for NDA: 212045
Mechanism of ActionOpioid Antagonists
Medical Subject Heading (MeSH) Categories for 212045
Suppliers and Packaging for NDA: 212045
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KLOXXADO naloxone hydrochloride SPRAY;NASAL 212045 NDA Hikma Specialty USA Inc. 59467-679 59467-679-01 .1 mL in 1 VIAL, SINGLE-DOSE (59467-679-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY;NASALStrength8MG/SPRAY
Approval Date:Apr 29, 2021TE:RLD:Yes
Regulatory Exclusivity Expiration:Apr 29, 2024
Regulatory Exclusivity Use:NEW PRODUCT
Patent:⤷  Sign UpPatent Expiration:Aug 26, 2034Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE OF NALOXONE FOR THE EMERGENCY TREATMENT OF KNOWN OR SUSPECTED OPIOID OVERDOSE, AS MANIFESTED BY RESPIRATORY AND/OR CENTRAL NERVOUS SYSTEM DEPRESSION, FOR ADULT AND PEDIATRIC PATIENTS
Patent:⤷  Sign UpPatent Expiration:Aug 26, 2034Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE OF NALOXONE FOR THE EMERGENCY TREATMENT OF KNOWN OR SUSPECTED OPIOID OVERDOSE, AS MANIFESTED BY RESPIRATORY AND/OR CENTRAL NERVOUS SYSTEM DEPRESSION, FOR ADULT AND PEDIATRIC PATIENTS

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.